Early valuable risk stratification with hemoglobin level and neutrophil to lymphocyte ratio in patients with non-ST-elevation myocardial infarction having an early invasive strategy
Parathyroid hormone levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with acetylsalicylic acid and clopidogrel or ticagrelor
Predictive and prognostic value of biomarkers of CI-AKI (contrast induced - acute kidney injury) in patients presenting with STEMI (ST-segment elevation myocardial infarction) treated by primary PCI